BCAX Earnings

Quarterly EPS
$-1.60
Q3 2024
$-0.38
Q4 2024
$-0.68
Q1 2025
$-0.50
Q2 2025
$-0.67
Q3 2025
$-0.68
Q4 2025
$-0.93
Q1 2026
$-0.82
Q2 2026
Latest RevenueN/A
Latest Net Income-55436000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.820-55436000-64.0%
Q1 2026-$0.930-56211000-36.8%
Q4 2025-$0.680-37386000-78.9%
Q3 2025-$0.670-36330000+58.1%
Q2 2025-$0.500-27388000
Q1 2025-$0.680-36846000
Q4 2024-$0.380-20957000
Q3 2024-$1.600-17481000
Bicara Therapeutics (BCAX) — Earnings